In this context, CD4+ Foxp3+ Tregs are a key source of host CD73 in TME, which is related to poor prognosis and chemoresistance in the TNBC and contributes to EMT-mediated trastuzumab resistance and TGF-β–mediated tumor immune escape[40]. Here, NT5E is linked to neoplasm.